Cargando…
ALKBH5 regulates anti–PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment
Although immune checkpoint blockade (ICB) therapy has revolutionized cancer treatment, many patients do not respond or develop resistance to ICB. N(6)-methylation of adenosine (m(6)A) in RNA regulates many pathophysiological processes. Here, we show that deletion of the m(6)A demethylase Alkbh5 sens...
Autores principales: | Li, Na, Kang, Yuqi, Wang, Lingling, Huff, Sarah, Tang, Rachel, Hui, Hui, Agrawal, Kriti, Gonzalez, Gwendolyn Michelle, Wang, Yinsheng, Patel, Sandip Pravin, Rana, Tariq M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443867/ https://www.ncbi.nlm.nih.gov/pubmed/32747553 http://dx.doi.org/10.1073/pnas.1918986117 |
Ejemplares similares
-
m(6)A RNA methyltransferases METTL3/14 regulate immune responses to anti‐PD‐1 therapy
por: Wang, Lingling, et al.
Publicado: (2020) -
Role of PCIF1‐mediated 5′‐cap N6‐methyladeonsine mRNA methylation in colorectal cancer and anti‐PD‐1 immunotherapy
por: Wang, Lingling, et al.
Publicado: (2022) -
m(6)A-RNA Demethylase FTO Inhibitors
Impair Self-Renewal in Glioblastoma Stem Cells
por: Huff, Sarah, et al.
Publicado: (2021) -
HIV reprograms host m(6)Am RNA methylome by viral Vpr protein-mediated degradation of PCIF1
por: Zhang, Qiong, et al.
Publicado: (2021) -
Small-molecule PTPN2 Inhibitors Sensitize Resistant Melanoma to Anti-PD-1 Immunotherapy
por: Zhu, Zhouting, et al.
Publicado: (2023)